SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001218
Filing Date
2022-05-10
Accepted
2022-05-09 17:58:36
Documents
58
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20220331x10q.htm   iXBRL 10-Q 1426352
2 EX-31.1 nwbo-20220331xex31d1.htm EX-31.1 11753
3 EX-32.1 nwbo-20220331xex32d1.htm EX-32.1 7482
  Complete submission text file 0001410578-22-001218.txt   6828352

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20220331.xsd EX-101.SCH 52311
5 EX-101.CAL nwbo-20220331_cal.xml EX-101.CAL 47363
6 EX-101.DEF nwbo-20220331_def.xml EX-101.DEF 194900
7 EX-101.LAB nwbo-20220331_lab.xml EX-101.LAB 351264
8 EX-101.PRE nwbo-20220331_pre.xml EX-101.PRE 288981
52 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20220331x10q_htm.xml XML 1497805
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 22906473
SIC: 2834 Pharmaceutical Preparations